iPrevailは、オンデマンドのサポートを提供するAI搭載のメンタルヘルス&ウェルネスプラットフォームです。認知行動療法(CBT)に基づいたパーソナライズされたプログラム、ピアコーチング、支援的なコミュニティを通じて、ユーザーがストレス、不安、うつ病、その他の感情的な課題を効果的かつ内密に管理するのを支援します。
製品概要
iprevail 製品概要
iPrevailは、オンデマンドのサポートを提供するAI搭載のメンタルヘルス&ウェルネスプラットフォームです。認知行動療法(CBT)に基づいたパーソナライズされたプログラム、ピアコーチング、支援的なコミュニティを通じて、ユーザーがストレス、不安、うつ病、その他の感情的な課題を効果的かつ内密に管理するのを支援します。
PsyFly 製品概要
PsyFlyは、24時間年中無休で利用可能なAI心理学者で、即座に専門的で機密性の高い心理的サポートを提供します。共感的なアプローチにより、ユーザーは予約なしでいつでも助けを得ることができます。
Detailed feature comparison
| Feature | iprevail | PsyFly |
|---|---|---|
| 主要カテゴリー | オンライン学習 | セラピー |
| 追加日 | 2025-08-15 | 2025-10-24 |
| 価格 | フリーミアム | フリーミアム |
| 公式サイト | www.iprevail.com | psyfly.netlify.app |
| 製品タイプ | ウェブサイト | ウェブサイト |
| Performance data | ||
| ユーザー評価 | 未確認 | 未確認 |
| コメント | 0 | 0 |
| 月間訪問数 | 17K | 3.6K |
| 月間成長率 | 0.9% | 未確認 |
| お気に入り | 128 | 111 |
| Details | 詳細を見る | 詳細を見る |
iprevail vs PsyFly monthly traffic
Compare iprevail and PsyFly by monthly reach, traffic trend, visit depth, top regions, and acquisition sources.
How to interpret the traffic data
In the iprevail vs PsyFly monthly traffic comparison, iprevail currently shows 17K visits and PsyFly shows 3.6K; iprevail has about 4.8 times the visible traffic of PsyFly, an absolute difference of about 13.4K visits. This reflects visible reach, not feature quality or paid users.
Only iprevail has complete third-party traffic details; PsyFly uses visits recorded inside ToolMage. These scopes cannot estimate market share directly, and on-site views should not be treated as the product’s total website traffic.
iprevail monthly traffic:
Latest traffic
Monthly traffic trend
- 2025/9: 18.2K 月間訪問数
- 2026/1: 33.5K 月間訪問数
- 2026/2: 18.2K 月間訪問数
- 2026/3: 13.8K 月間訪問数
- 2026/4: 16.8K 月間訪問数
- 2026/5: 17K 月間訪問数
主要地域
Top 5 countries/regions
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇺🇸United States | 100% | 17K |
流入元
| Source type | Percentage | Traffic |
|---|---|---|
| ダイレクト | 54.81% | 9.3K |
| Eメール | 26.79% | 4.5K |
| 参照元 | 18.4% | 3.1K |
検索キーワード
PsyFly monthly traffic:
Latest traffic
Usage comparison
Compare the core capabilities of iprevail and PsyFly
iprevail Core features
PsyFly Core features
Use cases
iprevail Use cases
PsyFly Use cases
Best suited roles
iprevail Best suited roles
PsyFly Best suited roles
iprevail vs PsyFly:In-depth comparison and selection guidance
First decide whether the products solve the same kind of need
This in-depth iprevail vs PsyFly comparison uses only the product records, taxonomy, audience, traffic, and community signals available on this page. iprevail is primarily listed under “オンライン学習”, while PsyFly is primarily listed under “セラピー”, so the first decision is whether your actual task matches their recorded scope.
The structured fields currently show these decision-relevant differences: Primary category (iprevail: オンライン学習; PsyFly: セラピー); Monthly visits (iprevail: 17K; PsyFly: 3.6K); Favorites (iprevail: 128; PsyFly: 111); Website (iprevail: www.iprevail.com; PsyFly: psyfly.netlify.app); Added (iprevail: 2025-08-15; PsyFly: 2025-10-24). These facts are more useful for selection than brand visibility alone.
What market visibility and monthly traffic mean
In the iprevail vs PsyFly monthly traffic comparison, iprevail currently shows 17K visits and PsyFly shows 3.6K; iprevail has about 4.8 times the visible traffic of PsyFly, an absolute difference of about 13.4K visits. This reflects visible reach, not feature quality or paid users.
Only iprevail has complete third-party traffic details; PsyFly uses visits recorded inside ToolMage. These scopes cannot estimate market share directly, and on-site views should not be treated as the product’s total website traffic.
The current traffic scope is not sufficient for a reliable product ranking. Treat monthly visits as a market-interest signal, then decide using taxonomy, use cases, pricing, and a like-for-like trial rather than reading exposure as product capability.
Product positioning, use cases, and roles
iprevail and PsyFly currently overlap in shared tags: オンラインセラピー、セルフケア、ウェルネス. This can place both on the same shortlist, but it does not prove equal implementation, depth, or cost.
iprevail's unique categories/tags are オンライン学習、メンタルヘルス、自己啓発、不安サポート、認知行動療法、うつ病のヘルプ、ピアサポート、ストレス管理; PsyFly's are セラピー、エモーショナルサポート、セルフケア、AI心理学者、AIセラピー、秘密療法、感情的サポート、即席のアドバイス. These unique fields are the strongest differentiators: validate the product whose recorded scope matches the task instead of following traffic alone.
What ratings, comments, and favorites can tell you
iprevail has no verified rating, 0 comments, 128 favorites, and 141 likes;PsyFly has no verified rating, 0 comments, 111 favorites, and 119 likes。
Neither product has enough rating or comment samples for a credible reputation ranking.
Selection guidance by actual need
When to evaluate iprevail first
Put iprevail on the priority trial list when the task aligns with “オンライン学習” and especially オンライン学習、メンタルヘルス、自己啓発、不安サポート、認知行動療法、うつ病のヘルプ. This follows recorded positioning and does not imply unlisted capabilities are absent.
iprevail also currently records: pricing is freemium, product type is website, 17K verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
When to evaluate PsyFly first
Put PsyFly on the priority trial list when the task aligns with “セラピー” and especially セラピー、エモーショナルサポート、セルフケア、AI心理学者、AIセラピー、秘密療法, or the users include メンタルヘルスサポートを求める個人、秘密のセルフケアツールを探している人、即時の感情的なガイダンスを必要とするユーザー. This follows recorded positioning and does not imply unlisted capabilities are absent.
PsyFly also currently records: pricing is freemium, product type is website, 3.6K on-site monthly views, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
How to validate the recommendation before deciding
The available data describes positioning, public visibility, and community signals, but it cannot prove output quality, speed, integration effort, privacy, or long-term cost in your workflow. Before deciding, run the same representative tasks in iprevail and PsyFly, then record completion time, accuracy, manual corrections, and the real paid threshold. A like-for-like trial turns this comparison into a defensible adoption decision.




